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Cerebral angioplastyAbstract Purpose: To evaluate vasospasm and/or other possible mechanisms as a contributor to
poor outcome following aneurismal subarachnoid hemorrhage (SAH).
Materials and methods: Sixty patients with aneurismal SAH, and severe cerebral vasospasm
warranting endovascular angioplasty were included. Data included age, sex, bleeding severity,
number and territory of spastic arteries, angioplasty result, development of new infarcts and their
location relative to spastic territory. Final outcome was reported.
Results: There was strong correlation between outcome and both grade of hemorrhage and age.
Angioplasty was either successful (80%), equivocal (10%), failed (8.3%), or could not be done
(1.7%).
New Infarcts were found in 44/60 patients (73.3%). In 7 of which (16%) they were out of spastic
territory. The remaining 37 (84.1%) had infarcts anatomically related to spasm, of these, 28 had
successful angioplasty (75%).
No new infarcts were found in the remaining 16 patients (26.7%). There was no signiﬁcant corre-
lation between new infarcts and either successful angioplasty or outcome. However, when outcome
was correlated to infarcts within the spastic territory, it turned strongly signiﬁcant (p= 0.008).
Conclusion: Vasospasm and new infarcts have different pathophysiology. Only the coexistence of
both in the same territory signiﬁcantly correlates with poor outcome. Both are related to severity of
SAH.
 2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. All rights reserved.1. Introduction
In 1951, Ecker and Riemenschneider [1] published a small
study of patients with subarachnoid hemorrhage (SAH), in
which vasospasm was demonstrated angiographically, anded.
Fig. 1 Right ICA angiogram showing ACA spasm. Maximum
spasm noticed at the pericollosal origin (short arrow). The MCA
territory looks normal. Notice the aneurysm at A1–A2 junction
(long arrow).
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was established.
Earlier observations of the cortical surface revealed that
electrical, chemical, and mechanical stimuli often caused
arterial constriction [2] Echlin [3] demonstrated in 1942 that
this induced vasospasm could in turn impair cerebral blood
ﬂow (CBF). In 1949, Robertson [4] investigated cerebral
infarction after SAH, and was the ﬁrst to speculate on arterial
spasm as a possible cause.
In subsequent studies [5], researchers conﬁrmed that angio-
graphically demonstrated vasospasm is quite common after
aneurysm rupture and is frequently associated with clinical
evidence of cerebral ischemia. In 1965, Kagstrom et al. demon-
strated that vasospasm is usually ‘‘delayed’’ for at least 3 days
after the initial SAH. Other investigators have elaborated on
the association and temporal relationship between angiograph-
ically demonstrated and ‘‘clinical’’ vasospasm [6–9]. Consider-
able effort over the years has gone into clarifying the
pathogenesis, clinico-pathological associations, and treatment
of vasospasm.
More recently, several lines of evidence cast doubt on angi-
ographically conﬁrmed vasospasm as the sole cause of DINDs.
First, although large cerebral arteries contribute more to
vascular resistance than do arteries elsewhere in the body, their
contribution to the regulation of cerebral ﬂow (CBF) is still
relatively minor [10,11]. Marked constriction of large cerebral
arteries can occur without a decrease in parenchymal CBF
[12].
Second, there is poor correlation between the sites and
severity of angiographically conﬁrmed vasospasm and cerebral
ischemia whether symptomatic [13,14] or measured [15,16].
Symptoms and ﬁndings of DINDs often follow peak vaso-
spasm by several days. The presence and location of angio-
graphically demonstrated vasospasm fail to correlate with
areas of cerebral infarction in as many as one third of cases
[17]. There are cases in which documented SAH-induced ische-
mia occurs without vasospasm [18,15,19], and it is possible to
increase CBF in experimental vasospasm without reversing the
spasm itself [20,21] Minhas et al. [22] performed simultaneous
positron emission tomography and TCD ultrasonography
studies in patients after SAH. They did not observe a correla-
tion between the two, thereby ‘‘calling into question the tradi-
tional concept of large-vessel vasospasm.’’
Third, autopsy studies performed in patients after SAH
reveal that the majority of infarcts are widespread and scat-
tered, small, wedge-shaped, or laminar [23–25]. This pattern
is more consistent with small thromboembolic than with large
arterial spasms. Stoltenberg-Didinger [26] who studied 156
patients who died and had not undergone surgery, found that
76% had evidence of small infarcts. In contrast, fewer than 6%
had large, territorial lesions [27] .These small infarcts were
often located immediately beneath the thickest subarachnoid
clots. These ﬁndings and others prompted Neil-Dwyer and col-
leagues [28] to suggest diffuse microangiopathy as the major
cause of DINDs after aneurysmal SAH.
Fourth, in clinical practice there are several effective thera-
pies that are used to combat angiographically demonstrated
vasospasm. However, these treatments had less of an effect
on infarct burden or patient outcome [29–33] (see Figs. 1–3).
Treatments such as intracisternal implantation of nicardi-
pine pellets after SAH can reduce angiographically conﬁrmed
vasospasm but do not affect DINDs [34].In some studies investigators suggest that endovascular
treatment of aneurysms is associated with less frequent and
less severe angiographically demonstrated vasospasm than sur-
gical occlusion. However, this has occurred without a corre-
sponding improvement in outcome [35]. Finally, transluminal
angioplasty and intraarterial papaverine administration are
effective in reversing angiographically demonstrated vaso-
spasm. Nevertheless, their effect on patient outcome is less cer-
tain [36].
An alternative theory for DINDs is the possibility that
blood or its breakdown products are directly neurotoxic. How-
ever, in animal models of SAH [37–40] and models that involve
exposure to blood products, [41] ischemia invariably precedes
necrosis.
The aim of this work was to investigate how consistent is
vasospasm as a mechanism of delayed ischemic neurological
deﬁcit (DIND), and whether there are other possible mecha-
nisms that may contribute to delayed ischemia and/or poor
outcome, following aneurismal SAH.
2. Materials and methods
We have retrospectively reviewed the ﬁles of patients who have
been admitted to Nasser Institute Hospital, during the period
from 2006 to 2012, with CT-proven aneurismal subarachnoid
hemorrhage (SAH), and who had suffered severe cerebral
vasospasm warranting endovascular intervention by angio-
plasty. Patients with asymptomatic vasospasm and those with
symptomatic vasospasm that responded to medical treatment
have been excluded from the study cohort. Follow-up CT scan
was done for every patient at least once after angioplasty (prior
to discharge), and earlier whenever there was remarkable alter-
ation in the neurological status of the patient. If the CT study
was done less than 48 h of onset and showed negative result,
then it was repeated after 48 h.
Fig. 2 Left: Left vertebral angiogram showing vertebro-basilar junctional aneurysm (long arrow). Notice spastic left vertebral (short
arrows) and right PCA origin (dotted arrow). Right: Follow up angiogram after coiling and angioplasty.
Fig. 3 Left ICA angiogram showing spasm of distal left ICA
(dotted arrow), MCA and – infantile – PCA. Both ACAs look
markedly spastic (short arrows).
Table 1 Distribution of grade of hemorrhage.
Grade Number of patients
1 10
2 8
3 21
4 9
5 3
Not known 9
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rhage at CT, the territory and the number of spastic arteries at
angiography, the technical result of angioplasty at the end of
the procedure and the development of new infarcts at follow
up CT scan as well as the location of such infarcts in relation
to the spastic artery territory.The clinical severity of SAH was graded according to the
Hunt and Hess scale (from 1 to 5) [42]. The technical result
of angioplasty was classiﬁed into either success (restored
near-normal caliber and ﬂow through the plastied territory,
with no appreciable delay in comparison to non-affected terri-
tory) or failure.
The ﬁnal outcome of the patient was reported in terms of
modiﬁed Rankin scale (from 0 to 6) [43]. However, in order
to get fewer groups with more data samples, it was corrected
to 4 grade scale (from 0 to 3), where 0 = complete recovery,
1 = minor deﬁcit not interfering with patient’s activities,
2 = moderate disability (needs assistance), and 3 = severe dis-
ability (needs nursing care) or death.
Data were veriﬁed and coded prior to analysis. All data
were expressed as mean ± SD and frequencies for quantitative
and qualitative data respectively. Chi-square test has been per-
formed to evaluate the association between different qualita-
tive variables. The analysis has been performed using the
SPSS version 11.
3. Results
Sixty patients represented the cohort of this study, one third of
which were males (20 patients, 33.3%), vs. 40 females,
(66.7%). The range of age was 21–83 years (mean
age = 49.2 ± 13.6). The grade of hemorrhage was not
Table 2 Statistical clinical/technical data.
Parameter Availability of data Range Mean Std
Delay of clip/coil* 52 0–18 days 3.7 3.9
Delay of plasty* 56 3–77 days 9.7 10.1
No. of spastic aa** 60 1–11aa 6.0 2.6
No. of plastied aa*** 60 0–6aa 2.5 1.5
* Delay is based on the time between the onset of bleeding and the time of intervention.
** No. of spastic arteries seen at angiography.
*** Number of arteries treated with angioplasty.
114 A.H.M. Said, N.M.F. El-Ghandourmentioned in the ﬁles of 9 patients. For the remaining 51
patients the grade of hemorrhage is shown in Table 1.
There was strong signiﬁcant correlation between the grade
of bleeding and the ﬁnal outcome (p= 0.002).
All 60 patients had at least one or more spastic artery. Of
these, 59 patients (98.3%) underwent cerebral angioplasty for
vasospasm, while in one patient (1.7%) the procedure was ter-
minated upon failure to pass through a tortuous coiled ICA.
Angioplasty was technically successful in 48 patients (80%),
equivocal in 6 (10%) and failed in another 5 patients (8.3%).
Other clinical and technical statistical data are shown in
Table 2.
On follow up CT, new Infarcts were found in 44/60 patients
(73.3%), of which 7 patients (16%) had infarcts located out of
the spastic territory, while the remaining 37 had infarcts that
are anatomically related to spasm. In such 37 patients, 28
patients had undergone angioplasty that was technically suc-
cessful (75%), while in 9 patients (24.3%) angioplasty was
either failure, equivocal or not done.
In the remaining 16 patients (26.7%), there was no evidence
of newly developed infarcts (spasm only). All 16 patients
underwent angioplasty, but two of them (12.5%) were – tech-
nically – failure, as per the patients’ ﬁles.
The association between technically successful angioplasty
and the subsequent development of cerebral infarcts was statis-
tically insigniﬁcant (p= 0.131).
Patients were classiﬁed according to the clinical outcome
into 4 groups, (Table 3).
Signiﬁcant correlation was found between the clinical out-
come and the age of the patients the younger the patient the
better the outcome (p= 0.007).
The p value for statistical correlation of clinical outcome to
the number of spastic arteries and development of new infarcts
was equal to 0.47 and 0.066 respectively. However, when the
outcome was correlated to new infarcts within the spastic ter-
ritory, the p value dropped to 0.008.
Statistical correlation of the number of spastic arteries to
age, sex, grade of hemorrhage and the development of new
infarcts was always insigniﬁcant (p> 0.05).Table 3 Clinical outcome. Grade is based on modiﬁed
Rankin scale, corrected to 4 grade scale (see text).
Outcome grade No. of patients Percentage (%)
0 7 11.7
1 27 45.0
2 16 26.7
3 10 16.74. Discussion
All the patients included in this study had suffered severe vaso-
spasm that is related to a preceding episode of SAH. The
patients’ charts had shown that grading of vasospasm was
based on clinical assessment of the patient’s Modiﬁed Rankin
and/or Glasgow Coma Scales (GCS), in addition to trans-cra-
nial Doppler (TCD) and cerebral angiography ﬁndings. We
did not go deeply into the criteria for grading of vasospasm
in each case, which is beyond the scope of this work, and we
relied on the mere history that those patients had severe vaso-
spasm that warrants further intervention by angioplasty.
Although all patients were classiﬁed as severe vasospasm,
we have proposed the number of spastic arteries (as shown
in cerebral angiography) as a possible further sub-grading
for the severity of vasospasm.
The clinical grade of hemorrhage was assessed based on the
Hunt and Hess scale rather than the Fisher’s scale [44]. In a
number of cases, the grade of bleeding was mentioned as well
according to Fisher’s scale, which is merely based on CT imag-
ing. Since the assessment of vasospasm and follow up as well
as the ﬁnal outcome was mainly based on the clinical picture,
we believed that the Hunt and Hess scale might be more suit-
able, hence we omitted Fisher’s grade.
The ﬁnal patient’s outcome assessment was based on the
modiﬁed Rankin scale. While the original scale is graded from
0 to 6, we believed that such 7-grades scale might result in
many groups with fewer data samples, hence our decision to
downscale the results into a 4-grade system. From a statistical
point of view, this will help as we deal with fewer numbers of
groups with more data samples.
The development of new infarcts at follow up CT scan is a
crucial point in the context of this work. Our main effort was
directed toward the establishment (or denial) of etiological
relationship between the existing vasospasm and any newly
developed infarct(s) as well as its contribution to the ﬁnal clin-
ical outcome, and whether such relationship is statistically sig-
niﬁcant or not.
The basic assumption that severe vasospasm would result in
impaired blood ﬂow to the affected territory with subsequent
development of new infarct, has been tackled by many authors
and could not be established [10–12]. In our study, although
there was signiﬁcant coincidence between the spastic territory
and the location of the new infarcts, however, this assumption
is not applicable, as it does not take into consideration the fact
that the vasospasm has been interventionally reversed, with
subsequent restoration of the normal – or near normal – vessel
caliber. In other words, the spasm could be reversed but infarc-
tion could not be prevented, raising a question mark about the
mechanism of development of those infarcts.
Outcome of aneurismal subarachnoid hemorrhage 115The development of new infarcts – per se – was not signif-
icantly related to the outcome. However, such relation between
the development of new infarcts and the clinical outcome was
strongly signiﬁcant when these infarcts were located within the
spastic territory. In other words, it is the co-existence of vaso-
spasm and infarcts at the same territory that may contribute to
the poor outcome, although both of them are not signiﬁcantly
related to each other. This ﬁnding is supported by a study of
carotid artery stent placement [45], in which it has been con-
ﬁrmed that the combination of micro-emboli and impaired
CBF produces more damage than either one alone. This may
– possibly – raise the micro-embolic theory as a clue to answer
the other question about those infarcts out of the spastic terri-
tory: how they developed, and why they do not contribute to
outcome.
In addition, we have proposed that the more the number of
spastic arteries, the more severe the ischemia and – subse-
quently – the worse the outcome should be. However we found
that the clinical outcome had poorly correlated to the number
of spastic arteries. This assumption/sub-classiﬁcation of
severity of vasospasm based on the number of spastic arteries
could not be validated.
Fisher et al. [44] – and many others – had documented the
correlation between grade of bleeding and the subsequent
development/severity of vasospasm. In our current series, the
grade of bleeding was signiﬁcantly correlated to the clinical
outcome. Stoltenberg-Didinger and Schwarz [27] found that
76% of their patients had small infarcts close to the thickest
hematoma, vs. 6% who had large territorial infarcts, raising
the possibility of microangiopathy and/or thrombo-embolic
event, rather than large vessel spasm. Putting things together
would mean that: while the grade of hemorrhage is signiﬁ-
cantly correlated to the severity of vasospasm as well as to
the clinical outcome, however both of them are not signiﬁ-
cantly related to each other, but the coexistence of infarcts
and spasm is. This would raise the possibility of associated
micro-vascular and/or thrombo-embolic contribution in our
series. Unfortunately, the size and shape of infarcts were not
documented on the ﬁles in most of the cases.
We have found other supportive ﬁndings in the literature,
as well. Peltonen et al. [46] had documented the rise of the
coagulation markers in CSF and jugular venous blood shortly
after SAH. Romano and coworkers [47] performed TCD mon-
itoring of the middle cerebral artery for 30 min three times a
week during the intensive care unit stay of 23 patients with
ruptured aneurysms. Microembolic signals were detected in
70% of the patients and 32% of the insonated vessels. These
ﬁndings support the suggestion that a large number of emboli,
some of which may be causing symptomatic cerebral infarc-
tions, occur after SAH.
Furthermore, the anti-coagulant effect of many successful
DIND therapies may add support to the thrombo-embolic the-
ory. This applies to many therapeutic lines such as protease
inhibitors and hemodilution. Nimodipine, a Calcium channel
blocker has been approved to improve the outcome in patients
with SAH. However, there is no convincing evidence that
nimodipine affects the incidence of either angiographic or
symptomatic vasospasm, while its antiplatelet and ﬁbrinolytic
effects were documented [48,49].5. Summary
The grade of SAH has been documented in the literature to
signiﬁcantly correlate with the severity of vasospasm. We have
found signiﬁcant correlation between grade of SAH and poor
clinical outcome, however, both parameters (vasospasm and
outcome) are not signiﬁcantly related to each other. Moreover,
the development of new infarcts has been noticed in many
patients, again with no signiﬁcant correlation to outcome, or
to vasospasm. The presumed explanation is that vasospasm
and new infarcts have different pathophysiology. We have
found that it is the co-existence of both mechanisms in the
same territory that correlates with the poor outcome. Both
mechanisms – however – are related to the grade of the original
SAH.
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